Dubai's premarital genomic screening flagged 8% of couples as at risk

A mandatory, citywide premarital genomic screening programme in Dubai sequenced 782 genes in prospective couples and found that 8% were at risk of having children affected by a recessive disorder [s1]. The rate was significantly higher than that reported by a comparable Australian study, and it puts hard numbers on a screening approach that much of the Gulf is moving toward [s1].

How the programme works

The programme, described in Nature Medicine on 21 April 2026, enrolled prospective couples through 18 primary healthcare centres across Dubai and sequenced 782 genes implicated in autosomal recessive disorders [s1]. Recessive disorders are the relevant target: a child is affected only when both parents carry a disease-causing variant in the same gene, so screening couples rather than individuals is what identifies reproductive risk [s1].

Since the programme began, 1,000 couples had undergone testing at the time of the report [s1]. Of those, 79 — 8%, with a 95% confidence interval of 6.4 to 9.7 — were identified as carriers of disease-causing variants in the same gene, and therefore at risk of having affected children [s1].

Why the rate was higher

The authors compared their result directly with Mackenzie's Mission, a large Australian reproductive carrier-screening study, which reported an at-risk couple rate of 3.9% [s1]. The Dubai rate was significantly higher, at a reported P value below 0.0001 [s1]. The most common risk was for haemoglobinopathies — the inherited blood disorders that include thalassaemia and sickle cell disease — but the picture was not dominated by them: 59% of at-risk couples carried variants in 33 other genes [s1].

That breadth is the finding with the most practical weight. Premarital screening in the Gulf has historically focused on haemoglobinopathies, which are common in the region. A programme that sequences hundreds of genes finds that most of the reproductive risk it detects lies outside that traditional focus [s1].

The programme also turned up incidental diagnoses. Of the 158 carriers identified, four — 2.5%, with a confidence interval of 1.0 to 6.3 — were found to be homozygous for a pathogenic variant, meaning they carried two affected copies and would themselves be affected, not merely carriers [s1].

What couples did with the result

Screening only changes outcomes if people act on it. Of the 79 at-risk couples, 63 — 80% — elected to proceed with marriage while considering government-funded reproductive interventions, and 16 — 20% — chose not to proceed [s1].

That distribution is consistent with the broader regional evidence. A narrative review of carrier screening in high-consanguinity populations, published in the Journal of Community Genetics in July 2026, reported that a substantial share of at-risk couples — 50% to 67% — proceed with marriage after screening [s2]. The review found carrier-detection rates of 62% to 90% in population-level programmes, and concluded that effectiveness depends on culturally responsive counselling, community engagement and supportive legal and religious frameworks rather than on technology alone [s2].

The caveats

Two limits deserve emphasis. First, the review flags that limited population-specific genomic reference databases lead to high rates of variants of uncertain significance in these populations — results that cannot be cleanly classified as harmful or benign [s2]. A screening panel is only as good as the reference data behind its interpretations, and the Middle Eastern population has been underrepresented in the large global datasets [s2].

Second, the Nature Medicine report describes the first implementation of a citywide programme, and the 1,000-couple cohort is an early sample [s1]. The comparison with Mackenzie's Mission is informative but not a like-for-like trial; the populations, gene panels and enrolment differ. What the study demonstrates is feasibility and clinical yield at city scale — that a mandatory programme can be run through routine primary care and detect at-risk couples at a rate the authors present as clinically meaningful [s1].